Our commitment at Cystic Fibrosis Canada to ensure everyone with cystic fibrosis (CF) can live W/O Limits is more vital than ever!
Read MoreNews
All media inquiries can be directed to mediarelations@cysticfibrosis.ca or by calling 1-800-378-2233.
Cystic Fibrosis Canada is encouraged by a recent decision by Health Canada to approve the life-changing cystic fibrosis (CF) drug Trikafta for some living with rare mutations that lead to CF.
Read MoreGénome Québec and Cystic Fibrosis Canada announce the launch of the Tackle Rare, Orphan CFTR Mutations Competition to support research on rare mutations for which no treatment is available, with the long-term goal of developing novel therapies.
Read MoreCystic Fibrosis Canada has opened its annual grant competition for 2024. Canadian researchers with an interest in cystic fibrosis (CF), including its connection to diabetes and cancer, can now apply for funding to be awarded starting in early 2025.
Read MoreProgress has been made towards improving access to the life-changing cystic fibrosis (CF) medication, Trikafta, in Canada.
Read MoreCF Canada successfully hosted the virtual CF Canada Community Forum: "Unchartered Territories" on April 26, 2024. If you couldn’t make it to CF Canada’s Community Forum “Unchartered Territories" last week, CF Canada has you covered!
Read MoreIt is with great pleasure that Génome Québec and Cystic Fibrosis Canada join forces to create a new funding program to support omics research on cystic fibrosis.
Read MoreThe team at Cystic Fibrosis Canada is pleased to share our 2023-24 Impact Report.
Read MoreCystic Fibrosis Canada asks participants to take a #StepToward ending cystic fibrosis for all Canadians with cystic fibrosis.
Read MoreJust in time for cystic fibrosis awareness month, Cystic Fibrosis Canada is excited to be making our podcast debut with today’s launch of Breathless.
Read More